false 2021 Q3 0000746598 July 31 7,551 7,157 51,261,487 51,261,487 48,524,455 48,456,954 2,737,032 2,804,533 3,538,628 3,538,628 3,538,628 3,538,628 0000746598 2020-08-01 2021-04-30 xbrli:shares 0000746598 us-gaap:NonvotingCommonStockMember 2021-05-18 0000746598 us-gaap:CommonClassBMember 2021-05-18 iso4217:USD 0000746598 2021-04-30 0000746598 2020-07-31 0000746598 us-gaap:NonvotingCommonStockMember 2021-04-30 0000746598 us-gaap:NonvotingCommonStockMember 2020-07-31 0000746598 us-gaap:CommonClassBMember 2021-04-30 0000746598 us-gaap:CommonClassBMember 2020-07-31 0000746598 2021-02-01 2021-04-30 0000746598 2020-02-01 2020-04-30 0000746598 2019-08-01 2020-04-30 0000746598 us-gaap:RetainedEarningsMember 2021-02-01 2021-04-30 0000746598 us-gaap:RetainedEarningsMember 2020-02-01 2020-04-30 iso4217:USD xbrli:shares 0000746598 us-gaap:NonvotingCommonStockMember 2021-02-01 2021-04-30 0000746598 us-gaap:NonvotingCommonStockMember 2020-02-01 2020-04-30 0000746598 us-gaap:NonvotingCommonStockMember 2020-08-01 2021-04-30 0000746598 us-gaap:NonvotingCommonStockMember 2019-08-01 2020-04-30 0000746598 us-gaap:CommonClassBMember 2021-02-01 2021-04-30 0000746598 us-gaap:CommonClassBMember 2020-02-01 2020-04-30 0000746598 us-gaap:CommonClassBMember 2020-08-01 2021-04-30 0000746598 us-gaap:CommonClassBMember 2019-08-01 2020-04-30 0000746598 2019-07-31 0000746598 2020-04-30 0000746598 us-gaap:CustomerRelationshipsMember 2020-08-01 2021-04-30 0000746598 us-gaap:CustomerRelationshipsMember 2021-04-30 0000746598 us-gaap:CustomerRelationshipsMember 2020-08-01 2020-10-31 0000746598 us-gaap:CustomerRelationshipsMember 2020-07-31 0000746598 us-gaap:TradeNamesMember 2021-04-30 0000746598 us-gaap:TradeNamesMember 2020-07-31 0000746598 us-gaap:CommonStockMember 2021-01-31 0000746598 us-gaap:AdditionalPaidInCapitalMember 2021-01-31 0000746598 us-gaap:RetainedEarningsMember 2021-01-31 0000746598 us-gaap:TreasuryStockMember 2021-01-31 0000746598 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-31 0000746598 2021-01-31 0000746598 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-02-01 2021-04-30 0000746598 us-gaap:AdditionalPaidInCapitalMember 2021-02-01 2021-04-30 0000746598 us-gaap:TreasuryStockMember 2021-02-01 2021-04-30 0000746598 us-gaap:CommonStockMember 2021-04-30 0000746598 us-gaap:AdditionalPaidInCapitalMember 2021-04-30 0000746598 us-gaap:RetainedEarningsMember 2021-04-30 0000746598 us-gaap:TreasuryStockMember 2021-04-30 0000746598 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-04-30 0000746598 us-gaap:CommonStockMember 2020-07-31 0000746598 us-gaap:AdditionalPaidInCapitalMember 2020-07-31 0000746598 us-gaap:RetainedEarningsMember 2020-07-31 0000746598 us-gaap:TreasuryStockMember 2020-07-31 0000746598 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-07-31 0000746598 us-gaap:RetainedEarningsMember 2020-08-01 2021-04-30 0000746598 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-08-01 2021-04-30 0000746598 us-gaap:AdditionalPaidInCapitalMember 2020-08-01 2021-04-30 0000746598 us-gaap:TreasuryStockMember 2020-08-01 2021-04-30 0000746598 us-gaap:CommonStockMember 2020-01-31 0000746598 us-gaap:AdditionalPaidInCapitalMember 2020-01-31 0000746598 us-gaap:RetainedEarningsMember 2020-01-31 0000746598 us-gaap:TreasuryStockMember 2020-01-31 0000746598 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-31 0000746598 2020-01-31 0000746598 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-02-01 2020-04-30 0000746598 us-gaap:AdditionalPaidInCapitalMember 2020-02-01 2020-04-30 0000746598 us-gaap:TreasuryStockMember 2020-02-01 2020-04-30 0000746598 us-gaap:CommonStockMember 2020-04-30 0000746598 us-gaap:AdditionalPaidInCapitalMember 2020-04-30 0000746598 us-gaap:RetainedEarningsMember 2020-04-30 0000746598 us-gaap:TreasuryStockMember 2020-04-30 0000746598 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-04-30 0000746598 us-gaap:CommonStockMember 2019-07-31 0000746598 us-gaap:AdditionalPaidInCapitalMember 2019-07-31 0000746598 us-gaap:RetainedEarningsMember 2019-07-31 0000746598 us-gaap:TreasuryStockMember 2019-07-31 0000746598 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-07-31 0000746598 us-gaap:RetainedEarningsMember 2019-08-01 2020-04-30 0000746598 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-08-01 2020-04-30 0000746598 us-gaap:AdditionalPaidInCapitalMember 2019-08-01 2020-04-30 0000746598 us-gaap:TreasuryStockMember 2019-08-01 2020-04-30 0000746598 us-gaap:CashFlowHedgingMember 2020-07-31 0000746598 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2020-07-31 0000746598 us-gaap:AccumulatedTranslationAdjustmentMember 2020-07-31 0000746598 us-gaap:CashFlowHedgingMember 2020-08-01 2021-04-30 0000746598 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2020-08-01 2021-04-30 0000746598 us-gaap:AccumulatedTranslationAdjustmentMember 2020-08-01 2021-04-30 0000746598 us-gaap:CashFlowHedgingMember 2021-04-30 0000746598 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2021-04-30 0000746598 us-gaap:AccumulatedTranslationAdjustmentMember 2021-04-30 0000746598 us-gaap:CashFlowHedgingMember 2019-07-31 0000746598 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2019-07-31 0000746598 us-gaap:AccumulatedTranslationAdjustmentMember 2019-07-31 0000746598 us-gaap:CashFlowHedgingMember 2019-08-01 2020-04-30 0000746598 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2019-08-01 2020-04-30 0000746598 us-gaap:AccumulatedTranslationAdjustmentMember 2019-08-01 2020-04-30 0000746598 us-gaap:CashFlowHedgingMember 2020-04-30 0000746598 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2020-04-30 0000746598 us-gaap:AccumulatedTranslationAdjustmentMember 2020-04-30 0000746598 srt:AmericasMember brc:IdSolutionsMember 2021-02-01 2021-04-30 0000746598 srt:AmericasMember brc:IdSolutionsMember 2020-02-01 2020-04-30 0000746598 srt:AmericasMember brc:IdSolutionsMember 2020-08-01 2021-04-30 0000746598 srt:AmericasMember brc:IdSolutionsMember 2019-08-01 2020-04-30 0000746598 us-gaap:EMEAMember brc:IdSolutionsMember 2021-02-01 2021-04-30 0000746598 us-gaap:EMEAMember brc:IdSolutionsMember 2020-02-01 2020-04-30 0000746598 us-gaap:EMEAMember brc:IdSolutionsMember 2020-08-01 2021-04-30 0000746598 us-gaap:EMEAMember brc:IdSolutionsMember 2019-08-01 2020-04-30 0000746598 brc:IdSolutionsMember srt:AsiaPacificMember 2021-02-01 2021-04-30 0000746598 brc:IdSolutionsMember srt:AsiaPacificMember 2020-02-01 2020-04-30 0000746598 brc:IdSolutionsMember srt:AsiaPacificMember 2020-08-01 2021-04-30 0000746598 brc:IdSolutionsMember srt:AsiaPacificMember 2019-08-01 2020-04-30 0000746598 brc:IdSolutionsMember 2021-02-01 2021-04-30 0000746598 brc:IdSolutionsMember 2020-02-01 2020-04-30 0000746598 brc:IdSolutionsMember 2020-08-01 2021-04-30 0000746598 brc:IdSolutionsMember 2019-08-01 2020-04-30 0000746598 srt:AmericasMember brc:WorkplaceSafetyMember 2021-02-01 2021-04-30 0000746598 srt:AmericasMember brc:WorkplaceSafetyMember 2020-02-01 2020-04-30 0000746598 srt:AmericasMember brc:WorkplaceSafetyMember 2020-08-01 2021-04-30 0000746598 srt:AmericasMember brc:WorkplaceSafetyMember 2019-08-01 2020-04-30 0000746598 us-gaap:EMEAMember brc:WorkplaceSafetyMember 2021-02-01 2021-04-30 0000746598 us-gaap:EMEAMember brc:WorkplaceSafetyMember 2020-02-01 2020-04-30 0000746598 us-gaap:EMEAMember brc:WorkplaceSafetyMember 2020-08-01 2021-04-30 0000746598 us-gaap:EMEAMember brc:WorkplaceSafetyMember 2019-08-01 2020-04-30 0000746598 brc:WorkplaceSafetyMember srt:AsiaPacificMember 2021-02-01 2021-04-30 0000746598 brc:WorkplaceSafetyMember srt:AsiaPacificMember 2020-02-01 2020-04-30 0000746598 brc:WorkplaceSafetyMember srt:AsiaPacificMember 2020-08-01 2021-04-30 0000746598 brc:WorkplaceSafetyMember srt:AsiaPacificMember 2019-08-01 2020-04-30 0000746598 brc:WorkplaceSafetyMember 2021-02-01 2021-04-30 0000746598 brc:WorkplaceSafetyMember 2020-02-01 2020-04-30 0000746598 brc:WorkplaceSafetyMember 2020-08-01 2021-04-30 0000746598 brc:WorkplaceSafetyMember 2019-08-01 2020-04-30 0000746598 srt:AmericasMember 2021-02-01 2021-04-30 0000746598 srt:AmericasMember 2020-02-01 2020-04-30 0000746598 srt:AmericasMember 2020-08-01 2021-04-30 0000746598 srt:AmericasMember 2019-08-01 2020-04-30 0000746598 us-gaap:EMEAMember 2021-02-01 2021-04-30 0000746598 us-gaap:EMEAMember 2020-02-01 2020-04-30 0000746598 us-gaap:EMEAMember 2020-08-01 2021-04-30 0000746598 us-gaap:EMEAMember 2019-08-01 2020-04-30 0000746598 srt:AsiaPacificMember 2021-02-01 2021-04-30 0000746598 srt:AsiaPacificMember 2020-02-01 2020-04-30 0000746598 srt:AsiaPacificMember 2020-08-01 2021-04-30 0000746598 srt:AsiaPacificMember 2019-08-01 2020-04-30 0000746598 us-gaap:FairValueInputsLevel1Member us-gaap:OtherAssetsMember 2021-04-30 0000746598 us-gaap:FairValueInputsLevel1Member us-gaap:OtherAssetsMember 2020-07-31 0000746598 us-gaap:FairValueInputsLevel2Member us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember 2021-04-30 0000746598 us-gaap:FairValueInputsLevel2Member us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember 2020-07-31 0000746598 us-gaap:FairValueInputsLevel2Member us-gaap:OtherCurrentLiabilitiesMember 2021-04-30 0000746598 us-gaap:FairValueInputsLevel2Member us-gaap:OtherCurrentLiabilitiesMember 2020-07-31 0000746598 us-gaap:DesignatedAsHedgingInstrumentMember 2021-04-30 0000746598 us-gaap:DesignatedAsHedgingInstrumentMember 2020-07-31 0000746598 us-gaap:NondesignatedMember 2021-04-30 0000746598 us-gaap:NondesignatedMember 2020-07-31 0000746598 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember us-gaap:CashFlowHedgingMember 2021-04-30 0000746598 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherCurrentLiabilitiesMember us-gaap:CashFlowHedgingMember 2021-04-30 0000746598 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember us-gaap:CashFlowHedgingMember 2020-07-31 0000746598 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherCurrentLiabilitiesMember us-gaap:CashFlowHedgingMember 2020-07-31 0000746598 us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember us-gaap:NondesignatedMember us-gaap:CashFlowHedgingMember 2021-04-30 0000746598 us-gaap:NondesignatedMember us-gaap:OtherCurrentLiabilitiesMember us-gaap:CashFlowHedgingMember 2021-04-30 0000746598 us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember us-gaap:NondesignatedMember us-gaap:CashFlowHedgingMember 2020-07-31 0000746598 us-gaap:NondesignatedMember us-gaap:OtherCurrentLiabilitiesMember us-gaap:CashFlowHedgingMember 2020-07-31 0000746598 us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember 2021-04-30 0000746598 us-gaap:OtherCurrentLiabilitiesMember 2021-04-30 0000746598 us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember 2020-07-31 0000746598 us-gaap:OtherCurrentLiabilitiesMember 2020-07-31 utr:Rate 0000746598 us-gaap:SubsequentEventMember 2021-05-19 2021-05-19 0000746598 us-gaap:SubsequentEventMember 2021-05-19 0000746598 us-gaap:SubsequentEventMember 2021-07-30 2021-07-30 0000746598 us-gaap:SubsequentEventMember 2021-07-09 2021-07-09 xbrli:pure iso4217:EUR xbrli:shares iso4217:EUR
Table of Contents
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549

FORM 10-Q

☑ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Quarterly Period Ended April 30, 2021
OR

☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Transition Period from to
Commission File Number 1-14959

BRADY CORPORATION
(Exact name of registrant as specified in its charter)

Wisconsin |  | 39-0178960
(State or other jurisdiction of incorporation or organization) |  | (I.R.S. Employer Identification No.)

6555 West Good Hope Road
Milwaukee, Wisconsin 53233
(Address of principal executive offices and zip code)
(414) 358-6600
(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class | Trading Symbol | Name of each exchange on which registered
Class A Nonvoting Common Stock, par value $0.01 per share | BRC | New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☑ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☑ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer |  | ☑ | Accelerated filer |  | ☐ | Emerging growth company |  | ☐
Non-accelerated filer |  | ☐ | Smaller reporting company |  | ☐ |  |  |

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☑
As of May 18, 2021, there were 48,524,455 outstanding shares of Class A Nonvoting Common Stock and 3,538,628 shares of Class B Voting Common Stock. The Class B Voting Common Stock, all of which is held by affiliates of the Registrant, is the only voting stock.

Table of Contents
FORM 10-Q
BRADY CORPORATION
INDEX

| Page
PART I. Financial Information | 3
Item 1. F inancial Statements (Unaudited) | 3
Condensed Consolidated Balance Sheets | 3
Condensed Consolidated Statements of Income | 4
Condensed Consolidated Statements of Comprehensive Income | 5
Condensed Consolidated Statements of Cash Flows | 6
Notes to Condensed Consolidated Financial Statements | 7
Item 2. Management’s Discussion and Analysis of Results of Operations and Financial Condition | 16
Item 3. Quantitative and Qualitative Disclosures About Market Risk | 23
Item 4. Controls and Procedures | 23
PART II. Other Information | 24
Item 1A. Risk Factors | 24
Item 6. Exhibits | 25
Signatures | 26

2

Table of Contents
PART I. FINANCIAL INFORMATION
ITEM 1. FINANCIAL STATEMENTS
BRADY CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(Dollars in Thousands)

| April 30, 2021 |  | July 31, 2020
| (Unaudited) |  |
ASSETS |  |  |
Current assets: |  |  |
Cash and cash equivalents | $ | 321,801 |  |  | $ | 217,643 |
Accounts receivable, net of allowances for credit losses of $7,551 and $7,157, respectively | 163,381 |  |  | 146,181 |
Inventories | 122,847 |  |  | 135,662 |
Prepaid expenses and other current assets | 13,032 |  |  | 9,962 |
Total current assets | 621,061 |  |  | 509,448 |
Property, plant and equipment—net | 121,126 |  |  | 115,068 |
Goodwill | 422,091 |  |  | 416,034 |
Other intangible assets | 18,528 |  |  | 22,334 |
Deferred income taxes | 8,334 |  |  | 8,845 |
Operating lease assets | 37,622 |  |  | 41,899 |
Other assets | 31,415 |  |  | 28,838 |
Total | $ | 1,260,177 |  |  | $ | 1,142,466 |
LIABILITIES AND STOCKHOLDERS’ EQUITY |  |  |
Current liabilities: |  |  |
Accounts payable | $ | 72,234 |  |  | $ | 62,547 |
Accrued compensation and benefits | 69,621 |  |  | 41,546 |
Taxes, other than income taxes | 9,207 |  |  | 8,057 |
Accrued income taxes | 2,711 |  |  | 8,652 |
Current operating lease liabilities | 16,197 |  |  | 15,304 |
Other current liabilities | 51,145 |  |  | 49,782 |
Total current liabilities | 221,115 |  |  | 185,888 |
Long-term operating lease liabilities | 25,841 |  |  | 31,982 |
Other liabilities | 61,595 |  |  | 61,524 |
Total liabilities | 308,551 |  |  | 279,394 |
Stockholders’ equity: |  |  |
Class A nonvoting common stock—Issued 51,261,487 shares, and outstanding 48,524,455 and 48,456,954 shares, respectively | 513 |  |  | 513 |
Class B voting common stock—Issued and outstanding, 3,538,628 shares | 35 |  |  | 35 |
Additional paid-in capital | 336,957 |  |  | 331,761 |
Retained earnings | 771,797 |  |  | 704,456 |
Treasury stock—2,737,032 and 2,804,533 shares, respectively, of Class A nonvoting common stock, at cost | (109,128) |  |  | (107,216) |
Accumulated other comprehensive loss | (48,548) |  |  | (66,477) |
Total stockholders’ equity | 951,626 |  |  | 863,072 |
Total | $ | 1,260,177 |  |  | $ | 1,142,466 |

See Notes to Condensed Consolidated Financial Statements.
3

Table of Contents
BRADY CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(Dollars in Thousands, Except Per Share Amounts, Unaudited)

| Three months ended April 30, |  | Nine months ended April 30,
| 2021 |  | 2020 |  | 2021 |  | 2020
Net sales | $ | 295,503 |  |  | $ | 265,943 |  |  | $ | 838,568 |  |  | $ | 829,555 |
Cost of goods sold | 146,656 |  |  | 136,416 |  |  | 424,771 |  |  | 419,496 |
Gross margin | 148,847 |  |  | 129,527 |  |  | 413,797 |  |  | 410,059 |
Operating expenses: |  |  |  |  |  |  |
Research and development | 11,305 |  |  | 9,814 |  |  | 31,384 |  |  | 31,298 |
Selling, general and administrative | 90,817 |  |  | 83,223 |  |  | 256,088 |  |  | 260,136 |
Impairment charges | — |  |  | 13,821 |  |  | — |  |  | 13,821 |
Total operating expenses | 102,122 |  |  | 106,858 |  |  | 287,472 |  |  | 305,255 |
Operating income | 46,725 |  |  | 22,669 |  |  | 126,325 |  |  | 104,804 |
Other income (expense): |  |  |  |  |  |  |
Investment and other income | 1,181 |  |  | 112 |  |  | 3,372 |  |  | 3,252 |
Interest expense | (131) |  |  | (628) |  |  | (288) |  |  | (1,976) |
Income before income taxes and losses of unconsolidated affiliate | 47,775 |  |  | 22,153 |  |  | 129,409 |  |  | 106,080 |
Income tax expense | 10,229 |  |  | 8,520 |  |  | 27,017 |  |  | 21,396 |
Income before losses of unconsolidated affiliate | 37,546 |  |  | 13,633 |  |  | 102,392 |  |  | 84,684 |
Equity in losses of unconsolidated affiliate | (255) |  |  | — |  |  | (760) |  |  | — |
Net income | $ | 37,291 |  |  | $ | 13,633 |  |  | $ | 101,632 |  |  | $ | 84,684 |
Net income per Class A Nonvoting Common Share: |  |  |  |  |  |  |
Basic | $ | 0.72 |  |  | $ | 0.26 |  |  | $ | 1.95 |  |  | $ | 1.60 |
Diluted | $ | 0.71 |  |  | $ | 0.26 |  |  | $ | 1.94 |  |  | $ | 1.58 |
Dividends | $ | 0.22 |  |  | $ | 0.22 |  |  | $ | 0.66 |  |  | $ | 0.65 |
Net income per Class B Voting Common Share: |  |  |  |  |  |  |
Basic | $ | 0.72 |  |  | $ | 0.26 |  |  | $ | 1.94 |  |  | $ | 1.58 |
Diluted | $ | 0.71 |  |  | $ | 0.26 |  |  | $ | 1.93 |  |  | $ | 1.57 |
Dividends | $ | 0.22 |  |  | $ | 0.22 |  |  | $ | 0.64 |  |  | $ | 0.64 |
Weighted average common shares outstanding: |  |  |  |  |  |  |
Basic | 52,050 |  |  | 52,607 |  |  | 52,030 |  |  | 53,023 |
Diluted | 52,449 |  |  | 52,972 |  |  | 52,341 |  |  | 53,512 |

See Notes to Condensed Consolidated Financial Statements.
4

Table of Contents
BRADY CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(Dollars in Thousands, Unaudited)

| Three months ended April 30, |  | Nine months ended April 30,
| 2021 |  | 2020 |  | 2021 |  | 2020
Net income | $ | 37,291 |  |  | $ | 13,633 |  |  | $ | 101,632 |  |  | $ | 84,684 |
Other comprehensive income (loss): |  |  |  |  |  |  |
Foreign currency translation adjustments | 2,891 |  |  | (17,424) |  |  | 17,773 |  |  | (18,383) |
Cash flow hedges: |  |  |  |  |  |  |
Net gain (loss) recognized in other comprehensive income (loss) | 118 |  |  | (1,751) |  |  | 1,266 |  |  | (1,192) |
Reclassification adjustment for gains included in net income | (292) |  |  | (293) |  |  | (21) |  |  | (779) |
| (174) |  |  | (2,044) |  |  | 1,245 |  |  | (1,971) |
Pension and other post-retirement benefits: |  |  |  |  |  |  |
Net loss recognized in other comprehensive income (loss) | — |  |  | — |  |  | (32) |  |  | (309) |
Net actuarial gain amortization | (105) |  |  | (105) |  |  | (306) |  |  | (315) |
| (105) |  |  | (105) |  |  | (338) |  |  | (624) |
Other comprehensive income (loss), before tax | 2,612 |  |  | (19,573) |  |  | 18,680 |  |  | (20,978) |
Income tax benefit (expense) related to items of other comprehensive income (loss) | 301 |  |  | (179) |  |  | (751) |  |  | (10) |
Other comprehensive income (loss), net of tax | 2,913 |  |  | (19,752) |  |  | 17,929 |  |  | (20,988) |
Comprehensive income (loss) | $ | 40,204 |  |  | $ | (6,119) |  |  | $ | 119,561 |  |  | $ | 63,696 |

See Notes to Condensed Consolidated Financial Statements.
5

Table of Contents
BRADY CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Dollars in Thousands, Unaudited)

| Nine months ended April 30,
| 2021 |  | 2020
Operating activities: |  |  |
Net income | $ | 101,632 |  |  | $ | 84,684 |
Adjustments to reconcile net income to net cash provided by operating activities: |  |  |
Depreciation and amortization | 17,240 |  |  | 17,731 |
Stock-based compensation expense | 8,003 |  |  | 7,180 |
Deferred income taxes | (3,957) |  |  | (309) |
Impairment charges | — |  |  | 13,821 |
Equity in losses of unconsolidated affiliate | 760 |  |  | — |
Other | (1,186) |  |  | 1,698 |
Changes in operating assets and liabilities: |  |  |
Accounts receivable | (13,247) |  |  | 9,019 |
Inventories | 15,210 |  |  | (7,439) |
Prepaid expenses and other assets | (2,584) |  |  | (5,653) |
Accounts payable and accrued liabilities | 39,244 |  |  | (26,609) |
Income taxes | (6,207) |  |  | 1,790 |
Net cash provided by operating activities | 154,908 |  |  | 95,913 |
Investing activities: |  |  |
Purchases of property, plant and equipment | (21,411) |  |  | (21,616) |
Other | 2,567 |  |  | (4,419) |
Net cash used in investing activities | (18,844) |  |  | (26,035) |
Financing activities: |  |  |
Payment of dividends | (34,290) |  |  | (34,447) |
Proceeds from exercise of stock options | 1,612 |  |  | 5,212 |
Payments for employee taxes withheld from stock-based awards | (2,772) |  |  | (7,832) |
Purchase of treasury stock | (3,593) |  |  | (64,113) |
Other | (231) |  |  | 133 |
Net cash used in financing activities | (39,274) |  |  | (101,047) |
Effect of exchange rate changes on cash | 7,368 |  |  | (9,023) |
Net increase (decrease) in cash and cash equivalents | 104,158 |  |  | (40,192) |
Cash and cash equivalents, beginning of period | 217,643 |  |  | 279,072 |
Cash and cash equivalents, end of period | $ | 321,801 |  |  | $ | 238,880 |

See Notes to Condensed Consolidated Financial Statements.
6

Table of Contents
BRADY CORPORATION AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
Nine Months Ended April 30, 2021
(Unaudited)
(In thousands, except share and per share amounts)
NOTE A — Basis of Presentation
The condensed consolidated financial statements included herein have been prepared by Brady Corporation and subsidiaries (the "Company," "Brady," "we," or "our") without audit, pursuant to the rules and regulations of the Securities and Exchange Commission. In the opinion of the Company, the foregoing statements contain all adjustments, consisting only of normal recurring adjustments necessary to present fairly the financial position of the Company as of April 30, 2021 and July 31, 2020, its results of operations and comprehensive income for the three and nine months ended April 30, 2021 and 2020, and cash flows for the nine months ended April 30, 2021 and 2020. The condensed consolidated balance sheet as of July 31, 2020, has been derived from the audited consolidated financial statements as of that date. The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts therein. Due to the inherent uncertainty involved in making estimates, actual results in future periods may differ from the estimates.
Certain information and footnote disclosures normally included in financial statements prepared in accordance with GAAP have been omitted pursuant to rules and regulations of the Securities and Exchange Commission. Accordingly, the condensed consolidated financial statements do not include all of the information and footnotes required by GAAP for complete financial statement presentation. It is suggested that these condensed consolidated financial statements be read in conjunction with the consolidated financial statements and the notes thereto included in the Company’s Annual Report on Form 10-K for the year ended July 31, 2020.
NOTE B — New Accounting Pronouncements
Adopted Standards
In June 2016, the FASB issued ASU 2016-13, "Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments," which changes the impairment model for most financial instruments. Prior guidance required the recognition of credit losses based on an incurred loss impairment methodology that reflected losses once the losses were probable. Under ASU 2016-13, the Company is required to use a current expected credit loss model ("CECL") that immediately recognizes an estimate of credit losses that are expected to occur over the life of the financial instruments that are in the scope of this update, including trade receivables. The Company adopted ASU 2016-13 effective August 1, 2020, which did not have a material impact on its consolidated financial statements.
In January 2017, the FASB issued ASU 2017-04, "Goodwill and Other, Simplifying the Test for Goodwill Impairment." The new guidance removes Step 2 of the goodwill impairment test, which required a hypothetical purchase price allocation. A goodwill impairment is now the amount by which a reporting unit’s carrying value exceeds its fair value, not to exceed the carrying amount of goodwill. All other goodwill impairment guidance remains largely unchanged. The Company adopted ASC 2017-04 effective August 1, 2020. This guidance only impacts the Company's consolidated financial statements if there is a future impairment of goodwill.
Standards not yet adopted
In December 2019, the FASB issued ASU 2019-12, "Income Taxes - Simplifying the Accounting for Income Taxes (Topic 740)." The new guidance removes certain exceptions to the general principles in ASC 740 such as recognizing deferred taxes for equity investments, the incremental approach to performing intraperiod tax allocation and calculating income taxes in interim periods. The standard also simplifies accounting for income taxes under U.S. GAAP by clarifying and amending existing guidance, including the recognition of deferred taxes for goodwill, the allocation of taxes to members of a consolidated group and requiring that an entity reflect the effect of enacted changes in tax laws or rates in the annual effective tax rate computation in the interim period that includes the enactment date. This guidance is effective for annual periods beginning after Dec ember 15, 2020, and interim periods thereafter. Early adoption is permitted. The Company is currently evaluating the impact that the adoption of this ASU will have on the consolidated financial statements and related disclosures.
In March 2020, the FASB issued ASU 2020-04, "Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting." Subject to meeting certain criteria, the new guidance provides optional expedients and exceptions to applying contract modification accounting under existing U.S. GAAP, to address the expected
7

Table of Contents
phase out of the London Inter-bank Offered Rate ("LIBOR") by the end of 2021. This guidance was effective upon issuance and allows application to contract changes as early as January 1, 2020. Some of the Company's contracts with respect to its borrowing agreements already contain comparable alternative reference rates that would automatically take effect upon the phasing out of LIBOR. The Company does not expect a material impact to the financial statements or disclosures.
NOTE C — Additional Balance Sheet Information
Inventories
Inventories as of April 30, 2021, and July 31, 2020, consisted of the following:

| April 30, 2021 |  | July 31, 2020
Finished products | $ | 78,484 |  |  | $ | 85,547 |
Work-in-process | 20,886 |  |  | 24,044 |
Raw materials and supplies | 23,477 |  |  | 26,071 |
Total inventories | $ | 122,847 |  |  | $ | 135,662 |

Property, plant and equipment
Property, plant and equipment is presented net of accumulated depreciation in the amount of $274,961 and $276,248 as of April 30, 2021, and July 31, 2020, respectively.
NOTE D — Other Intangible Assets
Other intangible assets as of April 30, 2021 and July 31, 2020, consisted of the following:

| April 30, 2021 |  | July 31, 2020
| Weighted Average Amortization Period (Years) |  | Gross Carrying Amount |  | Accumulated Amortization |  | Net Book Value |  | Weighted Average Amortization Period (Years) |  | Gross Carrying Amount |  | Accumulated Amortization |  | Net Book Value
Definite-lived other intangible assets: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Customer relationships and tradenames | 9 |  | $ | 45,497 |  |  | $ | (36,783) |  |  | $ | 8,714 |  |  | 9 |  | $ | 45,385 |  |  | $ | (32,670) |  |  | $ | 12,715 |
Indefinite-lived other intangible assets: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Tradenames | N/A |  | 9,814 |  |  | — |  |  | 9,814 |  |  | N/A |  | 9,619 |  |  | — |  |  | 9,619 |
Total |  |  | $ | 55,311 |  |  | $ | (36,783) |  |  | $ | 18,528 |  |  |  |  | $ | 55,004 |  |  | $ | (32,670) |  |  | $ | 22,334 |

The change in the gross carrying amount of other intangible assets as of April 30, 2021 compared to July 31, 2020 was due to the effect of currency fluctuations during the nine-month period.
Amortization expense of intangible assets was $1,352 and $1,290 for the three months ended April 30, 2021 and 2020, respectively, and $4,056 and $3,872 for the nine months ended April 30, 2021 and 2020, respectively. Amortization expense over each of the next three fiscal years is projected to be $5,408, $5,121, and $2,241 for the fiscal years ending July 31, 2021, 2022, and 2023. No amortization expense for intangible assets is projected after July 31, 2023.
NOTE E — Leases
The Company leases certain manufacturing facilities, warehouses and office space, computer equipment, and vehicles accounted for as operating leases. Lease terms typically range from one year to ten years. As of April 30, 2021, the Company did not have any finance leases.
Operating lease expense was $4,714 and $4,219 for the three months ended April 30, 2021 and 2020, respectively, and $12,956 and $13,897 for the nine months ended April 30, 2021 and 2020, respectively. Operating lease expense was recognized in either "Cost of goods sold" or "Selling, general and administrative" expenses in the condensed consolidated statements of income, based on the nature of the lease. Short-term lease expense, variable lease expenses, and sublease income was immaterial to the condensed consolidated statements of income for the three and nine months ended April 30, 2021 and 2020.
8

Table of Contents
Supplemental cash flow information related to the Company's operating leases for the nine months ended April 30, 2021 and 2020, was as follows:

| Nine months ended April 30,
| 2021 |  | 2020
Operating cash outflows from operating leases | $ | 13,965 |  |  | $ | 12,469 |
Operating lease assets obtained in exchange for new operating lease liabilities | 5,832 |  |  | 10,637 |

NOTE F – Stockholders' Equity
The following table illustrates the changes in the balances of each component of stockholders' equity for the three months ended April 30, 2021:

|  | Common Stock |  | Additional Paid-In Capital |  | Retained Earnings |  | Treasury Stock |  | Accumulated Other Comprehensive Loss |  | Total Stockholders' Equity
Balances at January 31, 2021 |  | $ | 548 |  |  | $ | 334,077 |  |  | $ | 745,960 |  |  | $ | (109,789) |  |  | $ | (51,461) |  |  | $ | 919,335 |
Net income |  | — |  |  | — |  |  | 37,291 |  |  | — |  |  | — |  |  | 37,291 |
Other comprehensive income, net of tax |  | — |  |  | — |  |  | — |  |  | — |  |  | 2,913 |  |  | 2,913 |
Issuance of shares of Class A Common Stock under stock plan |  | — |  |  | 348 |  |  | — |  |  | 661 |  |  | — |  |  | 1,009 |
Stock-based compensation expense |  | — |  |  | 2,532 |  |  | — |  |  | — |  |  | — |  |  | 2,532 |
Cash dividends on Common Stock: |  |  |  |  |  |  |  |  |  |  |  |
Class A — $0.2200 per share |  | — |  |  | — |  |  | (10,675) |  |  | — |  |  | — |  |  | (10,675) |
Class B — $0.2200 per share |  | — |  |  | — |  |  | (779) |  |  | — |  |  | — |  |  | (779) |
Balances at April 30, 2021 |  | $ | 548 |  |  | $ | 336,957 |  |  | $ | 771,797 |  |  | $ | (109,128) |  |  | $ | (48,548) |  |  | $ | 951,626 |

The following table illustrates the changes in the balances of each component of stockholders' equity for the nine months ended April 30, 2021:

|  | Common Stock |  | Additional Paid-In Capital |  | Retained Earnings |  | Treasury Stock |  | Accumulated Other Comprehensive Loss |  | Total Stockholders' Equity
Balances at July 31, 2020 |  | $ | 548 |  |  | $ | 331,761 |  |  | $ | 704,456 |  |  | $ | (107,216) |  |  | $ | (66,477) |  |  | $ | 863,072 |
Net income |  | — |  |  | — |  |  | 101,632 |  |  | — |  |  | — |  |  | 101,632 |
Other comprehensive income, net of tax |  | — |  |  | — |  |  | — |  |  | — |  |  | 17,929 |  |  | 17,929 |
Issuance of shares of Class A Common Stock under stock plan |  | — |  |  | (2,839) |  |  | — |  |  | 1,681 |  |  | — |  |  | (1,158) |
Tax benefit and withholdings from deferred compensation distributions |  | — |  |  | 32 |  |  | — |  |  | — |  |  | — |  |  | 32 |
Stock-based compensation expense |  | — |  |  | 8,003 |  |  | — |  |  | — |  |  | — |  |  | 8,003 |
Repurchase of shares of Class A Common Stock |  | — |  |  | — |  |  | — |  |  | (3,593) |  |  | — |  |  | (3,593) |
Cash dividends on Common Stock: |  |  |  |  |  |  |  |  |  |  |  |
Class A — $0.6600 per share |  | — |  |  | — |  |  | (32,013) |  |  | — |  |  | — |  |  | (32,013) |
Class B — $0.6434 per share |  | — |  |  | — |  |  | (2,278) |  |  | — |  |  | — |  |  | (2,278) |
Balances at April 30, 2021 |  | $ | 548 |  |  | $ | 336,957 |  |  | $ | 771,797 |  |  | $ | (109,128) |  |  | $ | (48,548) |  |  | $ | 951,626 |

9

Table of Contents
The following table illustrates the changes in the balances of each component of stockholders' equity for the three months ended April 30, 2020:

|  | Common Stock |  | Additional Paid-In Capital |  | Retained Earnings |  | Treasury Stock |  | Accumulated Other Comprehensive Loss |  | Total Stockholders' Equity
Balances at January 31, 2020 |  | $ | 548 |  |  | $ | 329,263 |  |  | $ | 685,758 |  |  | $ | (43,155) |  |  | $ | (72,490) |  |  | $ | 899,924 |
Net income |  | — |  |  | — |  |  | 13,633 |  |  | — |  |  | — |  |  | 13,633 |
Other comprehensive loss, net of tax |  | — |  |  | — |  |  | — |  |  | — |  |  | (19,752) |  |  | (19,752) |
Issuance of shares of Class A Common Stock under stock plan |  | — |  |  | (91) |  |  | — |  |  | 517 |  |  | — |  |  | 426 |
Stock-based compensation expense |  | — |  |  | 1,796 |  |  | — |  |  | — |  |  | — |  |  | 1,796 |
Repurchase of shares of Class A Common Stock |  | — |  |  | — |  |  | — |  |  | (64,113) |  |  | — |  |  | (64,113) |
Cash dividends on Common Stock: |  |  |  |  |  |  |  |  |  |  |  |
Class A — $0.2175 per share |  | — |  |  | — |  |  | (10,542) |  |  | — |  |  | — |  |  | (10,542) |
Class B — $0.2175 per share |  | — |  |  | — |  |  | (770) |  |  | — |  |  | — |  |  | (770) |
Balances at April 30, 2020 |  | $ | 548 |  |  | $ | 330,968 |  |  | $ | 688,079 |  |  | $ | (106,751) |  |  | $ | (92,242) |  |  | $ | 820,602 |

The following table illustrates the changes in the balances of each component of stockholders' equity for the nine months ended April 30, 2020:

|  | Common Stock |  | Additional Paid-In Capital |  | Retained Earnings |  | Treasury Stock |  | Accumulated Other Comprehensive Loss |  | Total Stockholders' Equity
Balances at July 31, 2019 |  | $ | 548 |  |  | $ | 329,969 |  |  | $ | 637,843 |  |  | $ | (46,332) |  |  | $ | (71,254) |  |  | $ | 850,774 |
Net income |  | — |  |  | — |  |  | 84,684 |  |  | — |  |  | — |  |  | 84,684 |
Other comprehensive loss, net of tax |  | — |  |  | — |  |  | — |  |  | — |  |  | (20,988) |  |  | (20,988) |
Issuance of shares of Class A Common Stock under stock plan |  | — |  |  | (6,314) |  |  | — |  |  | 3,694 |  |  | — |  |  | (2,620) |
Tax benefit and withholdings from deferred compensation distributions |  | — |  |  | 133 |  |  | — |  |  | — |  |  | — |  |  | 133 |
Stock-based compensation expense |  | — |  |  | 7,180 |  |  | — |  |  | — |  |  | — |  |  | 7,180 |
Repurchase of shares of Class A Common Stock |  | — |  |  | — |  |  | — |  |  | (64,113) |  |  | — |  |  | (64,113) |
Cash dividends on Common Stock: |  |  |  |  |  |  |  |  |  |  |  |
Class A — $0.6525 per share |  | — |  |  | — |  |  | (32,197) |  |  | — |  |  | — |  |  | (32,197) |
Class B — $0.6359 per share |  | — |  |  | — |  |  | (2,251) |  |  | — |  |  | — |  |  | (2,251) |
Balances at April 30, 2020 |  | $ | 548 |  |  | $ | 330,968 |  |  | $ | 688,079 |  |  | $ | (106,751) |  |  | $ | (92,242) |  |  | $ | 820,602 |

10

Table of Contents
NOTE G — Accumulated Other Comprehensive Loss
Other comprehensive loss consists of foreign currency translation adjustments which includes the settlements of net investment hedges, unrealized gains and losses from cash flow hedges, and the unamortized gain on post-retirement plans, net of their related tax effects.
The following table illustrates the changes in the balances of each component of accumulated other comprehensive loss, net of tax, for the nine months ended April 30, 2021:

| Unrealized (loss) gain on cash flow hedges |  | Unamortized gain on post-retirement plans |  | Foreign currency translation adjustments |  | Accumulated other comprehensive loss
Beginning balance, July 31, 2020 | $ | (200) |  |  | $ | 2,181 |  |  | $ | (68,458) |  |  | $ | (66,477) |
Other comprehensive income (loss) before reclassification | 1,189 |  |  | (23) |  |  | 16,848 |  |  | 18,014 |
Amounts reclassified from accumulated other comprehensive loss | (16) |  |  | (69) |  |  | — |  |  | (85) |
Ending balance, April 30, 2021 | $ | 973 |  |  | $ | 2,089 |  |  | $ | (51,610) |  |  | $ | (48,548) |

The decrease in accumulated other comprehensive loss as of April 30, 2021 compared to July 31, 2020, was primarily due to the depreciation of the U.S. dollar against certain other currencies during the nine-month period.
The following table illustrates the changes in the balances of each component of accumulated other comprehensive loss, net of tax, for the nine months ended April 30, 2020:

| Unrealized gain (loss) on cash flow hedges |  | Unamortized gain on post-retirement plans |  | Foreign currency translation adjustments |  | Accumulated other comprehensive loss
Beginning balance, July 31, 2019 | $ | 707 |  |  | $ | 2,800 |  |  | $ | (74,761) |  |  | $ | (71,254) |
Other comprehensive loss before reclassification | (1,363) |  |  | (216) |  |  | (18,510) |  |  | (20,089) |
Amounts reclassified from accumulated other comprehensive loss | (584) |  |  | (315) |  |  | — |  |  | (899) |
Ending balance, April 30, 2020 | $ | (1,240) |  |  | $ | 2,269 |  |  | $ | (93,271) |  |  | $ | (92,242) |

The increase in accumulated other comprehensive loss as of April 30, 2020, compared to July 31, 2019, was primarily due to the appreciation of the U.S. dollar against certain other currencies during the nine-month period.
Of the amounts reclassified from accumulated other comprehensive loss during the nine months ended April 30, 2021 and 2020, unrealized gains on cash flow hedges were reclassified to "Cost of goods sold" and net unamortized gains on post-retirement plans were reclassified into "Investment and other income" on the condensed consolidated statements of income.
The following table illustrates the income tax benefit (expense) on the components of other comprehensive income (loss) for the three and nine months ended April 30, 2021 and 2020:

| Three months ended April 30, |  | Nine months ended April 30,
| 2021 |  | 2020 |  | 2021 |  | 2020
Income tax benefit (expense) related to items of other comprehensive income (loss): |  |  |  |  |  |  |
Cash flow hedges | $ | (71) |  |  | $ | (6) |  |  | $ | (72) |  |  | $ | 24 |
Pension and other post-retirement benefits | — |  |  | — |  |  | 246 |  |  | 93 |
Other income tax adjustments and currency translation | 372 |  |  | (173) |  |  | (925) |  |  | (127) |
Income tax benefit (expense) related to items of other comprehensive income (loss) | $ | 301 |  |  | $ | (179) |  |  | $ | (751) |  |  | $ | (10) |

11

Table of Contents
NOTE H — Revenue Recognition
The Company recognizes revenue when control of the product or service transfers to the customer at an amount that represents the consideration expected to be received in exchange for those products and services. The Company’s revenues are primarily from the sale of identification solutions and workplace safety products that are shipped and billed to customers. All revenue is from contracts with customers and is included in “Net sales” on the condensed consolidated statements of income. See Note I, “Segment Information,” for the Company’s disaggregated revenue disclosure.
The Company offers extended warranty coverage that is included in the sales price of certain products, which it accounts for as service warranties. The Company accounts for the deferred revenue associated with extended service warranties as a contract liability. The balance of contract liabilities associated with service warranty performance obligations was $2,567 and $2,559 as of April 30, 2021 and July 31, 2020, respectively. The current portion and non-current portion of contract liabilities are included in “Other current liabilities” and “Other liabilities," respectively, on the condensed consolidated balance sheets. The Company recognized revenue of $291 and $317 during the three months ended April 30, 2021 and 2020, respectively, and $882 and $948 during the nine months ended April 30, 2021 and 2020, respectively, that was included in the contract liability balance at the beginning of the respective period from the amortization of extended service warranties. Of the contract liability balance outstanding at April 30, 2021, the Company expects to recognize 11% by the end of fiscal 2021, an additional 38% by the end of fiscal 2022, and the remaining balance thereafter.
NOTE I — Segment Information
The Company is organized and managed on a global basis within three operating segments, Identification Solutions ("IDS"), Workplace Safety ("WPS"), and People Identification ("PDC"), which aggregate into two reportable segments that are organized around businesses with consistent products and services: IDS and WPS. The IDS and PDC operating segments aggregate into the IDS reporting segment, while the WPS reporting segment is comprised solely of the Workplace Safety operating segment.
The following is a summary of net sales by segment and geographic region for the three and nine months ended April 30, 2021 and 2020:

| Three months ended April 30, |  | Nine months ended April 30,
| 2021 |  | 2020 |  | 2021 |  | 2020
Net sales: |  |  |  |  |  |  |
ID Solutions |  |  |  |  |  |  |
Americas | $ | 143,348 |  |  | $ | 131,169 |  |  | $ | 401,585 |  |  | $ | 418,440 |
Europe | 50,416 |  |  | 41,183 |  |  | 137,038 |  |  | 129,884 |
Asia | 24,301 |  |  | 20,817 |  |  | 71,861 |  |  | 65,194 |
Total | $ | 218,065 |  |  | $ | 193,169 |  |  | $ | 610,484 |  |  | $ | 613,518 |
Workplace Safety |  |  |  |  |  |  |
Americas | $ | 21,425 |  |  | $ | 21,456 |  |  | $ | 65,656 |  |  | $ | 69,395 |
Europe | 42,491 |  |  | 37,567 |  |  | 123,922 |  |  | 110,594 |
Australia | 13,522 |  |  | 13,751 |  |  | 38,506 |  |  | 36,048 |
Total | $ | 77,438 |  |  | $ | 72,774 |  |  | $ | 228,084 |  |  | $ | 216,037 |
Total Company |  |  |  |  |  |  |
Americas | $ | 164,773 |  |  | $ | 152,625 |  |  | $ | 467,241 |  |  | $ | 487,835 |
Europe | 92,907 |  |  | 78,750 |  |  | 260,960 |  |  | 240,478 |
Asia-Pacific | 37,823 |  |  | 34,568 |  |  | 110,367 |  |  | 101,242 |
Total | $ | 295,503 |  |  | $ | 265,943 |  |  | $ | 838,568 |  |  | $ | 829,555 |

The following is a summary of segment profit for the three and nine months ended April 30, 2021 and 2020:

| Three months ended April 30, |  | Nine months ended April 30,
| 2021 |  | 2020 |  | 2021 |  | 2020
Segment profit: |  |  |  |  |  |  |
ID Solutions | $ | 47,539 |  |  | $ | 36,401 |  |  | $ | 126,818 |  |  | $ | 119,499 |
Workplace Safety | 5,656 |  |  | 4,379 |  |  | 17,107 |  |  | 14,991 |
Total Company | $ | 53,195 |  |  | $ | 40,780 |  |  | $ | 143,925 |  |  | $ | 134,490 |

12

Table of Contents
The following is a reconciliation of segment profit to income before income taxes and losses of unconsolidated affiliate for the three and nine months ended April 30, 2021 and 2020:

| Three months ended April 30, |  | Nine months ended April 30,
| 2021 |  | 2020 |  | 2021 |  | 2020
Total profit from reportable segments | $ | 53,195 |  |  | $ | 40,780 |  |  | $ | 143,925 |  |  | $ | 134,490 |
Unallocated amounts: |  |  |  |  |  |  |
Administrative costs | (6,470) |  |  | (4,290) |  |  | (17,600) |  |  | (15,865) |
Impairment charges | — |  |  | (13,821) |  |  | — |  |  | (13,821) |
Investment and other income | 1,181 |  |  | 112 |  |  | 3,372 |  |  | 3,252 |
Interest expense | (131) |  |  | (628) |  |  | (288) |  |  | (1,976) |
Income before income taxes and losses of unconsolidated affiliate | $ | 47,775 |  |  | $ | 22,153 |  |  | $ | 129,409 |  |  | $ | 106,080 |

NOTE J — Net Income per Common Share
The following table summarizes the computation of basic and diluted net income per share for the Company’s Class A and Class B common stock:

| Three months ended April 30, |  | Nine months ended April 30,
| 2021 |  | 2020 |  | 2021 |  | 2020
Numerator (in thousands): |  |  |  |  |  |  |
Net Income (Numerator for basic and diluted income per Class A Nonvoting Common Share) | $ | 37,291 |  |  | $ | 13,633 |  |  | $ | 101,632 |  |  | $ | 84,684 |
Less: |  |  |  |  |  |  |
Preferential dividends | — |  |  | — |  |  | (808) |  |  | (828) |
Preferential dividends on dilutive stock options | — |  |  | — |  |  | (4) |  |  | (10) |
Numerator for basic and diluted income per Class B Voting Common Share | $ | 37,291 |  |  | $ | 13,633 |  |  | $ | 100,820 |  |  | $ | 83,846 |
Denominator: (in thousands) |  |  |  |  |  |  |
Denominator for basic income per share for both Class A and Class B | 52,050 |  |  | 52,607 |  |  | 52,030 |  |  | 53,023 |
Plus: Effect of dilutive equity awards | 399 |  |  | 365 |  |  | 311 |  |  | 489 |
Denominator for diluted income per share for both Class A and Class B | 52,449 |  |  | 52,972 |  |  | 52,341 |  |  | 53,512 |
Net income per Class A Nonvoting Common Share: |  |  |  |  |  |  |
Basic | $ | 0.72 |  |  | $ | 0.26 |  |  | $ | 1.95 |  |  | $ | 1.60 |
Diluted | $ | 0.71 |  |  | $ | 0.26 |  |  | $ | 1.94 |  |  | $ | 1.58 |
Net income per Class B Voting Common Share: |  |  |  |  |  |  |
Basic | $ | 0.72 |  |  | $ | 0.26 |  |  | $ | 1.94 |  |  | $ | 1.58 |
Diluted | $ | 0.71 |  |  | $ | 0.26 |  |  | $ | 1.93 |  |  | $ | 1.57 |

Potentially dilutive securities attributable to outstanding stock options and restricted stock units were excluded from the calculation of diluted net income per share where the combined exercise price and average unamortized fair value were greater than the average market price of Brady's Class A Nonvoting Common Stock because the effect would have been anti-dilutive. The amount of anti-dilutive shares was 239,707 and 488,932 for the three months ended April 30, 2021 and 2020, respectively, and 603,356 and 353,752 for the nine months ended April 30, 2021 and 2020, respectively.
13

Table of Contents
NOTE K — Fair Value Measurements
In accordance with fair value accounting guidance, the Company determines fair value based on the exchange price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. The inputs used to measure fair value are classified into the following hierarchy:
Level 1 — Unadjusted quoted prices in active markets for identical instruments that are accessible as of the reporting date.
Level 2 — Other significant pricing inputs that are either directly or indirectly observable.
Level 3 — Significant unobservable pricing inputs, which result in the use of management's own assumptions.
The following table summarizes the Company's financial assets and liabilities that were accounted for at fair value on a recurring basis at April 30, 2021 and July 31, 2020:

| April 30, 2021 |  | July 31, 2020 |  | Fair Value Hierarchy
Assets: |  |  |  |  |
Trading securities | $ | 20,169 |  |  | $ | 18,606 |  |  | Level 1
Foreign exchange contracts | 724 |  |  | 594 |  |  | Level 2
Liabilities: |  |  |  |  |
Foreign exchange contracts | 252 |  |  | 777 |  |  | Level 2

The following methods and assumptions were used to estimate the fair value of each class of financial instrument:
Trading securities: The Company’s deferred compensation investments consist of investments in mutual funds, which are included in "Other assets" on the condensed consolidated balance sheets. These investments were classified as Level 1 as the shares of these investments trade with sufficient frequency and volume to enable us to obtain pricing information on an ongoing basis.
Foreign exchange contracts: The Company’s foreign exchange contracts were classified as Level 2 as the fair value was based on the present value of the future cash flows using external models that use observable inputs, such as interest rates, yield curves and foreign exchange rates. See Note L, “Derivatives and Hedging Activities,” for additional information.
The fair values of cash and cash equivalents, accounts receivable, accounts payable, and other liabilities approximated carrying values due to their short-term nature.
NOTE L — Derivatives and Hedging Activities
The Company utilizes forward foreign exchange currency contracts to reduce the exchange rate risk of specific foreign currency denominated transactions. These contracts typically require the exchange of a foreign currency for U.S. dollars at a fixed rate at a future date, with maturities of less than 18 months, which qualify as cash flow hedges or net investment hedges under the accounting guidance for derivative instruments and hedging activities. The primary objective of the Company’s foreign currency exchange risk management program is to minimize the impact of currency movements due to transactions in other than the respective subsidiaries’ functional currency and to minimize the impact of currency movements on the Company’s net investment denominated in a currency other than the U.S. dollar. To achieve this objective, the Company hedges a portion of known exposures using forward foreign exchange currency contracts.
Main foreign currency exposures are related to transactions denominated in the British Pound, Euro, Canadian dollar, Australian dollar, Mexican Peso, Chinese Yuan, Malaysian Ringgit and Singapore dollar. Generally, these risk management transactions will involve the use of foreign currency derivatives to minimize the impact of currency movements on non-functional currency transactions.
The U.S. dollar equivalent notional amounts of outstanding forward exchange contracts were as follows:

| April 30, 2021 |  | July 31, 2020
Designated as cash flow hedges | $ | 6,150 |  |  | $ | 24,600 |
Non-designated hedges | 3,495 |  |  | 3,107 |
Total foreign exchange contracts | $ | 9,645 |  |  | $ | 27,707 |

14

Table of Contents
Cash Flow Hedges
The Company has designated a portion of its forward foreign exchange contracts as cash flow hedges and recorded these contracts at fair value on the condensed consolidated balance sheets. For these instruments, the effective portion of the gain or loss on the derivative is reported as a component of other comprehensive income ("OCI") and reclassified into income in the same period or periods during which the hedged transaction affects income. As of April 30, 2021 and July 31, 2020, unrealized gains of $860 and losses of $385 have been included in OCI, respectively.
The following table summarizes the amount of pre-tax gains and losses related to foreign exchange contracts designated as cash flow hedging instruments:

| Three months ended April 30, |  | Nine months ended April 30,
| 2021 |  | 2020 |  | 2021 |  | 2020
Gains (losses) recognized in OCI | $ | 118 |  |  | $ | (1,751) |  |  | $ | 1,266 |  |  | $ | (1,192) |
Gains reclassified from OCI into cost of goods sold | 292 |  |  | 293 |  |  | 21 |  |  | 779 |

Fair values of derivative instruments in the condensed consolidated balance sheets were as follows:

| April 30, 2021 |  | July 31, 2020
| Prepaid expenses and other current assets |  | Other current liabilities |  | Prepaid expenses and other current assets |  | Other current liabilities
Derivatives designated as hedging instruments: |  |  |  |  |  |  |
Foreign exchange contracts (cash flow hedges) | $ | 724 |  |  | $ | 242 |  |  | $ | 588 |  |  | $ | 761 |
Derivatives not designated as hedging instruments: |  |  |  |  |  |  |
Foreign exchange contracts (non-designated hedges) | — |  |  | 10 |  |  | 6 |  |  | 16 |
Total derivative instruments | $ | 724 |  |  | $ | 252 |  |  | $ | 594 |  |  | $ | 777 |

NOTE M — Income Taxes
The effective income tax rate for the three and nine months ended April 30, 2021, was 21.4% and 20.9%, respectively. The Company expects its annual effective income tax rate to approximate 20% over the long-term based on its current global business mix and based on current tax laws and statutory tax rates in effect. However, quarterly tax rates could vary substantially based on the respective facts and circumstances at that point in time.
The effective income tax rate for the three and nine months ended April 30, 2020, was 38.5% and 20.2%, respectively. The effective income tax rate for the three months ended April 30, 2020 was higher than the expected income tax rate due to an increase in the valuation allowance against foreign tax credit carryforwards resulting from a decrease in the Company's expectations of future foreign source income.
NOTE N — Subsequent Events
On May 19, 2021, the Board of Directors declared a quarterly cash dividend to shareholders of the Company’s Class A and Class B Common Stock of $0.22 per share payable on July 30, 2021, to shareholders of record at the close of business on July 9, 2021.
On May 19, 2021, the results of the Company’s cash tender offer for all of the outstanding, publicly-held shares of Nordic ID Oyj (“Nordic ID”) were finalized. According to the final results of the cash tender offer, the shares of Nordic ID that were validly tendered represent 92.9% of all outstanding shares and votes of Nordic ID. The Company intends to complete the cash tender offer on or about May 21, 2021, following which the Company intends to acquire all of the remaining outstanding shares of Nordic ID and cause Nordic ID to apply for delisting of its shares from Nasdaq First North Growth Market Finland. The cash consideration offered for each Nordic ID Share validly tendered in the Tender Offer is EUR 3.30 per share, which equates to a total equity purchase of EUR 8.1 million (USD 9.9 million), plus the assumption of debt of approximately USD 3 million.
15

Table of Contents
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF RESULTS OF OPERATIONS AND FINANCIAL CONDITION
Overview
Brady Corporation is a global manufacturer and supplier of identification solutions and workplace safety products that identify and protect premises, products and people. The IDS segment is primarily involved in the design, manufacture, and distribution of high-performance and innovative safety, identification and healthcare products. The WPS segment provides workplace safety, identification and compliance products, approximately half of which are internally manufactured and half of which are externally sourced.
The ability to provide customers with a broad range of proprietary, customized and diverse products for use in various applications across multiple industries and geographies, along with a commitment to quality and service, have made Brady a leader in many of its markets. The long-term sales growth and profitability of our segments will depend not only on improved demand in end markets and the overall economic environment, but also on our ability to continuously improve the efficiency of our global operations, deliver a high level of customer service, develop and market innovative new products, and to advance our digital capabilities. In our IDS business, our strategy for growth includes an increased focus on certain industries and products, a focus on improving the customer buying experience, and the development of technologically advanced, innovative and proprietary products. In our WPS business, our strategy for growth includes a focus on workplace safety critical industries, innovative new product offerings, compliance expertise, customization expertise, and improving our digital capabilities.
The following are key initiatives supporting our strategy in fiscal 2021:
•Investing in organic growth by enhancing our research and development process and utilizing customer feedback to develop innovative new products.
•Investing in acquisitions that enhance our strategic position and accelerate sales growth.
•Providing our customers with the highest level of customer service.
•Expanding and enhancing our sales capabilities through an improved digital presence and the use of data-driven marketing automation tools.
•Driving operational excellence and executing sustainable efficiency gains within our selling, general and administrative structures and within our global operations including insourcing of critical products and manufacturing activities.
•Building on our culture of diversity and inclusion to increase employee engagement and enhance recruitment and retention practices.
Impact of the COVID-19 Pandemic on Our Business
Brady Corporation is deemed an essential business under the majority of local government orders. Our products support first responders, healthcare workers, food processing companies, and many other critical industries. During the three and nine months ended April 30, 2021, our facilities were operating globally with enhanced safety protocols designed to protect the health and safety of our employees.
We have taken actions throughout our business to reduce controllable costs, including actions to reduce labor costs, eliminate non-essential travel, and reduce discretionary spend. We believe we have the financial strength to continue to invest in organic sales growth opportunities, inorganic sales opportunities, and research and development ("R&D"), while continuing to drive sustainable efficiencies and automation in our operations and selling, general and administrative ("SG&A") functions. At April 30, 2021, we had cash of $321.8 million, an undrawn credit facility of $200 million, which can be increased up to $400 million at the Company's option and subject to certain conditions, and outstanding letters of credit of $3.6 million, for total available liquidity of approximately $718 million.
We believe that our financial resources, liquidity levels and debt-free status are sufficient to manage the impact of the COVID-19 pandemic, which may result in reduced sales, reduced net income, and reduced cash provided by operating activities. Refer to Risk Factors, included in Part I, Item 1A of our Annual Report on Form 10-K for the year ended July 31, 2020, along with Risks Factors, included in Part II, Item IA of this Quarterly Report on Form 10-Q for the period ended April 30, 2021, for further discussion of the possible impact of the COVID-19 pandemic on our business.
16

Table of Contents
Results of Operations
A comparison of results of operating income for the three and nine months ended April 30, 2021 and 2020, is as follows:

| Three months ended April 30, |  | Nine months ended April 30,
(Dollars in thousands) | 2021 |  | % Sales |  | 2020 |  | % Sales |  | 2021 |  | % Sales |  | 2020 |  | % Sales
Net sales | $ | 295,503 |  |  |  |  | $ | 265,943 |  |  |  |  | $ | 838,568 |  |  |  |  | $ | 829,555 |  |  |
Gross margin | 148,847 |  |  | 50.4 | % |  | 129,527 |  |  | 48.7 | % |  | 413,797 |  |  | 49.3 | % |  | 410,059 |  |  | 49.4 | %
Operating expenses: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Research and development | 11,305 |  |  | 3.8 | % |  | 9,814 |  |  | 3.7 | % |  | 31,384 |  |  | 3.7 | % |  | 31,298 |  |  | 3.8 | %
Selling, general and administrative | 90,817 |  |  | 30.7 | % |  | 83,223 |  |  | 31.3 | % |  | 256,088 |  |  | 30.5 | % |  | 260,136 |  |  | 31.4 | %
Impairment charges | — |  |  | — | % |  | 13,821 |  |  | 5.2 | % |  | — |  |  | — | % |  | 13,821 |  |  | 1.7 | %
Total operating expenses | 102,122 |  |  | 34.6 | % |  | 106,858 |  |  | 40.2 | % |  | 287,472 |  |  | 34.3 | % |  | 305,255 |  |  | 36.8 | %
Operating income | $ | 46,725 |  |  | 15.8 | % |  | $ | 22,669 |  |  | 8.5 | % |  | $ | 126,325 |  |  | 15.1 | % |  | $ | 104,804 |  |  | 12.6 | %

References in this Form 10-Q to “organic sales” refer to sales calculated in accordance with GAAP, excluding the impact of foreign currency translation. The Company's organic sales disclosures exclude the effects of foreign currency translation as foreign currency translation is subject to volatility that can obscure underlying business trends. Management believes that the non-GAAP financial measure of organic sales is meaningful to investors as it provides them with useful information to aid in identifying underlying sales trends in our businesses and facilitating comparisons of our sales performance with prior periods.
Net sales for the three months ended April 30, 2021, increased 11.1% to $295.5 million, compared to $265.9 million in the same period of the prior year. The increase consisted of an organic sales growth of 6.5% and a positive currency impact of 4.6% due to the weakening of the U.S. Dollar against certain other currencies as compared to the same period in the prior year. Organic sales grew 9.8% in the IDS segment and declined 2.2% in the WPS segment during the three months ended April 30, 2021, compared to the same period in the prior year.
The most significant impact on organic sales due to the COVID-19 pandemic started in the second half of fiscal 2020 when varied government responses to the pandemic impacted a large demographic of our customers and the overall global economy. The IDS segment realized reduced demand across all major product lines beginning in the third quarter fiscal 2020, while the WPS segment realized essentially flat organic sales in the third quarter in fiscal 2020 primarily due to increased sales of personal protective equipment and other pandemic-related products which offset decreased demand in other core products. For the three months ended April 30, 2021, the COVID-19 pandemic continued to affect sales in the IDS and WPS segments, although to a much lesser extent compared to the same period in the prior year.
Net sales for the nine months ended April 30, 2021, increased 1.1% to $838.6 million, compared to $829.6 million in the same period of the prior year. The increase consisted of an organic sales decline of 1.7% and a positive currency impact of 2.8%. Organic sales declined 2.1% in the IDS segment and declined 0.5% in the WPS segment during the nine months ended April 30, 2021, compared to the same period in the prior year. The COVID-19 pandemic had a significant impact on organic sales during the nine months ended April 30, 2021, with the impact varying between the IDS and WPS segments.
Gross margin increased 14.9% to $148.8 million in the three months ended April 30, 2021, compared to $129.5 million in the same period in the prior year. As a percentage of net sales, gross margin increased to 50.4% compared to 48.7% in the same period in the prior year. The increase was due to the increase in sales volumes in our IDS business, which was partially offset by a decrease in gross margin in our WPS business due to product mix. Gross margin increased 0.9% to $413.8 million for the nine months ended April 30, 2021, compared to $410.1 million in the same period in the prior year. As a percentage of net sales, gross margin decreased to 49.3% compared to 49.4% in the same period in the prior year. The decrease in gross margin during the nine-month period was due to reduced sales volumes in both IDS and WPS as well as product mix in our WPS business.
R&D expenses increased 15.2% to $11.3 million and increased 0.3% to $31.4 million for the three and nine months ended April 30, 2021, respectively, compared to $9.8 million and $31.3 million in the same periods in the prior year. As a percentage of sales, R&D expenses remained essentially flat for both the three and nine months ended April 30, 2021, compared to the same periods of the prior year. The increase in R&D spending for both the three and nine-month periods was primarily due to an increase in incentive-based compensation, which was partially offset by a decrease in headcount, improved efficiency, and the timing of expenditures related to ongoing new product development costs compared to the same periods in the prior year. The Company remains committed to investing in new product development to increase sales within our IDS and WPS businesses. Investments in new printers and materials continue to be the primary focus of R&D expenditures.
17

Table of Contents
SG&A expenses include selling and administration costs directly attributed to the IDS and WPS segments, as well as certain other corporate administrative expenses including finance, information technology, human resources, and other administrative expenses. SG&A expenses increased 9.1% to $90.8 million in the three months ended April 30, 2021, compared to $83.2 million in the same period in the prior year. As a percentage of net sales, SG&A decreased to 30.7% compared to 31.3% in the same period in the prior year. The increase in SG&A expenses was primarily due to increased incentive compensation compared to the lower than normal incentive compensation in the prior year, and foreign currency translation. The decrease as a percentage of net sales was due to a reduction in the SG&A cost structure and a reduction in discretionary spend including a decrease in travel for our sales people when compared to the same period in the prior year.
SG&A expenses decreased 1.6% to $256.1 million for the nine months ended April 30, 2021, compared to $260.1 million in the same period in the prior year. As a percentage of net sales, SG&A decreased to 30.5% from 31.4% in the same period in the prior year. The decrease in SG&A was due to a reduction in the SG&A cost structure and a reduction in discretionary spend including a decrease in travel for our sales people when compared to the same period in the prior year, which was partially offset by an increase in incentive compensation and foreign currency translation.
As a result of the global economic slowdown that began during the three months ended April 30, 2020 due to the COVID-19 pandemic, management evaluated whether indicators of impairment of intangible assets and other long-lived assets existed. Management concluded that the COVID-19 pandemic resulted in indicators of impairment in certain businesses within the WPS and IDS segments, and performed an interim impairment analysis. As a result of the analysis, impairment charges of $13.8 million related to other intangible and long-lived assets, primarily in the WPS segment, were recorded during the three months ended April 30, 2020.
Operating income increased 106.1% to $46.7 million and increased 20.5% to $126.3 million for the three and nine months ended April 30, 2021, respectively, compared to $22.7 million and $104.8 million in the same periods in the prior year. The increase in operating income in both the three and nine-month periods was primarily due to the increase in segment profit in the IDS segment and the impairment charge recognized during the period ended April 30, 2020.
OPERATING INCOME TO NET INCOME

| Three months ended April 30, |  | Nine months ended April 30,
(Dollars in thousands) | 2021 |  | % Sales |  | 2020 |  | % Sales |  | 2021 |  | % Sales |  | 2020 |  | % Sales
Operating income | $ | 46,725 |  |  | 15.8 | % |  | $ | 22,669 |  |  | 8.5 | % |  | $ | 126,325 |  |  | 15.1 | % |  | $ | 104,804 |  |  | 12.6 | %
Other income (expense): |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Investment and other income | 1,181 |  |  | 0.4 | % |  | 112 |  |  | — | % |  | 3,372 |  |  | 0.4 | % |  | 3,252 |  |  | 0.4 | %
Interest expense | (131) |  |  | — | % |  | (628) |  |  | (0.2) | % |  | (288) |  |  | — | % |  | (1,976) |  |  | (0.2) | %
Income before income tax and losses of unconsolidated affiliate | 47,775 |  |  | 16.2 | % |  | 22,153 |  |  | 8.3 | % |  | 129,409 |  |  | 15.4 | % |  | 106,080 |  |  | 12.8 | %
Income tax expense | 10,229 |  |  | 3.5 | % |  | 8,520 |  |  | 3.2 | % |  | 27,017 |  |  | 3.2 | % |  | 21,396 |  |  | 2.6 | %
Income before losses of unconsolidated affiliate | 37,546 |  |  | 12.7 | % |  | 13,633 |  |  | 5.1 | % |  | 102,392 |  |  | 12.2 | % |  | 84,684 |  |  | 10.2 | %
Equity in losses of unconsolidated affiliate | (255) |  |  | (0.1) | % |  | — |  |  | — | % |  | (760) |  |  | (0.1) | % |  | — |  |  | — | %
Net income | $ | 37,291 |  |  | 12.6 | % |  | $ | 13,633 |  |  | 5.1 | % |  | $ | 101,632 |  |  | 12.1 | % |  | $ | 84,684 |  |  | 10.2 | %

Investment and other income was $1.2 million and $0.1 million for the three months ended April 30, 2021 and 2020, respectively. The increase in the three-month period was primarily due to an increase in the market value of securities held in deferred compensation plans, which was partially offset by a decrease in interest income due to the decline in interest rates. Investment and other income was consistent at $3.4 million and $3.3 million for the nine months ended April 30, 2021 and 2020, respectively.
Interest expense decreased to $0.1 million and $0.3 million for the three and nine months ended April 30, 2021, respectively, compared to $0.6 million and $2.0 million in the same periods in the prior year. The decrease in interest expense for both the three and nine-month periods was due to the repayment of the Company's principal balance under its private placement debt agreement during the fourth quarter of fiscal 2020.
The Company's income tax rate was 21.4% and 38.5% for the three months ended April 30, 2021 and 2020, and the income tax rate was 20.9% and 20.2% for the nine months ended April 30, 2021 and 2020, respectively. Refer to Note M, "Income Taxes" for additional information on the Company's income tax rates.
18

Table of Contents
Equity in losses of unconsolidated affiliate of $0.3 million and $0.8 million for the three and nine months ended April 30, 2021, respectively, represented the Company's proportionate share of the loss in its equity interest in React Mobile, Inc., an employee safety software and hardware company based in the United States.
Business Segment Operating Results
The Company evaluates short-term segment performance based on segment profit and customer sales. Interest expense, investment and other income, income tax expense, equity in losses of unconsolidated affiliate, and certain corporate administrative expenses are excluded when evaluating segment performance.
The following is a summary of segment information for the three and nine months ended April 30, 2021, and 2020:

| Three months ended April 30, |  | Nine months ended April 30,
| 2021 |  | 2020 |  | 2021 |  | 2020
SALES GROWTH INFORMATION |  |  |  |  |  |  |
ID Solutions |  |  |  |  |  |  |
Organic | 9.8 | % |  | (8.2) | % |  | (2.1) | % |  | (3.2) | %
Currency | 3.1 | % |  | (1.5) | % |  | 1.6 | % |  | (1.1) | %
Total | 12.9 | % |  | (9.7) | % |  | (0.5) | % |  | (4.3) | %
Workplace Safety |  |  |  |  |  |  |
Organic | (2.2) | % |  | 0.2 | % |  | (0.5) | % |  | (0.5) | %
Currency | 8.6 | % |  | (4.1) | % |  | 6.1 | % |  | (3.1) | %
Total | 6.4 | % |  | (3.9) | % |  | 5.6 | % |  | (3.6) | %
Total Company |  |  |  |  |  |  |
Organic | 6.5 | % |  | (6.0) | % |  | (1.7) | % |  | (2.5) | %
Currency | 4.6 | % |  | (2.2) | % |  | 2.8 | % |  | (1.6) | %
Total | 11.1 | % |  | (8.2) | % |  | 1.1 | % |  | (4.1) | %
SEGMENT PROFIT AS A PERCENT OF NET SALES |  |  |  |  |  |  |
ID Solutions | 21.8 | % |  | 18.8 | % |  | 20.8 | % |  | 19.5 | %
Workplace Safety | 7.3 | % |  | 6.0 | % |  | 7.5 | % |  | 6.9 | %
Total | 18.0 | % |  | 15.3 | % |  | 17.2 | % |  | 16.2 | %

ID Solutions
IDS net sales increased 12.9% to $218.1 million for the three months ended April 30, 2021, compared to the same period in the prior year, which consisted of organic sales growth of 9.8% and an increase from foreign currency translation of 3.1%. The economic slowdown caused by the COVID-19 pandemic had a significant impact on organic sales trends in the three months ended April 30, 2021 and 2020. Organic sales recovered in all major product lines with growth in the safety and facility identification, healthcare identification, product identification, and wire identification product lines in the three months ended April 30, 2021. Demand increased in most end markets as economic activity improved following the disruption caused by the COVID-19 pandemic during the second half of fiscal 2020 and the first half of fiscal 2021.
IDS net sales declined 0.5% to $610.5 million for the nine months ended April 30, 2021, compared to the same period in the prior year, which consisted of an organic sales decline of 2.1% and an increase from foreign currency translation of 1.6%. Organic sales declined in the nine-month period due to reduced demand during the first half of the fiscal year resulting from the economic slowdown caused by the COVID-19 pandemic. Organic sales declined in the safety and facility identification and healthcare identification product lines, which was partially offset by organic sales growth in the product identification and wire identification product lines.
Organic sales in the Americas increased in the high-single digits for the three months ended April 30, 2021, compared to the same period in the prior year. Organic sales grew in all major product lines with growth in the wire identification, safety and facility identification, product identification, and healthcare identification product lines. Organic sales grew in the high-single digits in the United States and grew approximately 20% in the remainder of the Americas region for the three months ended April 30, 2021.
19

Table of Contents
Organic sales in the Americas declined in the low-single digits for the nine months ended April 30, 2021, compared to the same period in the prior year. Organic sales declined in the healthcare identification and safety and facility identification product lines due to reduced demand during the first half of the fiscal year resulting from the economic slowdown caused by the COVID-19 pandemic. This was partially offset by organic sales growth in the product identification and wire identification product lines. Organic sales declined in the low-single digits in the United States and grew in the mid-single digits in the remainder of the Americas region for the nine months ended April 30, 2021.
Organic sales in Europe increased in the low-double digits for the three months ended April 30, 2021, compared to the same period in the prior year. Organic sales grew in the safety and facility identification, product identification, and wire identification product lines. Organic sales growth was broad-based throughout both Western Europe and businesses based in emerging geographies primarily due to increased economic activity following the disruption caused by the COVID-19 pandemic.
Organic sales in Europe declined in the low-single digits for the nine months ended April 30, 2021, compared to the same period in the prior year. Organic sales declined in the healthcare identification product line primarily due to reduced demand from the economic slowdown caused by the COVID-19 pandemic, which was partially offset by organic sales growth in the product identification, safety and facility identification, and wire identification product lines. Organic sales declined throughout Western Europe which was partially offset by organic sales growth in emerging geographies during the nine-month period.
Organic sales in Asia increased in the low-double digits for the three months ended April 30, 2021, and increased in the mid-single digits for the nine months ended April 30, 2021, compared to the same periods in the prior year. Organic sales growth in both periods was primarily driven by growth in the product identification product line, and to a lesser extent growth in the wire identification and safety and facility identification product lines due to increased demand for industrial identification products. Organic sales in China grew in the low-single digits in both periods. Organic sales grew nearly 20% throughout the rest of Asia for the three-month period and grew in the high-single digits for the nine-month period ended April 30, 2021.
Segment profit increased 30.6% to $47.5 million for the three months ended April 30, 2021, compared to $36.4 million in the same period in the prior year. Segment profit increased 6.1% to $126.8 million for the nine months ended April 30, 2021, compared to $119.5 million for the same period in the prior year. As a percentage of net sales, segment profit increased to 21.8% from 18.8% for the three-month period, and segment profit increased to 20.8% from 19.5% for the nine-month period ended April 30, 2021 compared to the same periods in the prior year. The increase in segment profitability was due to increased sales volumes and an overall reduction in the cost structure throughout the IDS segment.
Workplace Safety
WPS net sales increased 6.4% to $77.4 million for the three months ended April 30, 2021, compared to the same period in the prior year, which consisted of an organic sales decline of 2.2% and an increase from foreign currency translation of 8.6%. The economic effect of the COVID-19 pandemic had a significant impact on organic sales trends during the second half of fiscal 2020. The WPS business refined its digital marketing efforts to focus on the increase in demand for personal protective equipment and other social distancing signage and floor markings resulting from the COVID-19 pandemic. These actions resulted in a significant increase in sales in these product categories while sales of core safety and identification products declined due to the economic disruption caused by the pandemic. WPS continues to sell COVID-19 pandemic-related products, but there was reduced demand for these products and sales did not replace the decline in demand for core safety and identification products in the three months ended April 30, 2021 compared to the same period in the prior year.
WPS net sales increased 5.6% to $228.1 million for the nine months ended April 30, 2021, compared to the same period in the prior year, which consisted of an organic sales decline of 0.5% and an increase from foreign currency translation of 6.1%. Due to the increased digital marketing efforts around demand for personal protective equipment and other social distancing signage and floor markings resulting from the COVID-19 pandemic, the business realized organic sales growth in the first half of fiscal 2021. WPS continues to sell COVID-19 pandemic-related products, but the demand for these products has declined and sales did not replace the decline in demand for core safety and identification products in the nine months ended April 30, 2021 compared to the same period in the prior year.
Organic sales in Europe increased in the low-single digits for the three and nine months ended April 30, 2021, compared to the same periods in the prior year. Digital sales increased in the mid-single digits in the three months and increased in the high-single digits in the nine months ended April 30, 2021, while sales through the catalog channel increased in the low-single digits in both periods. Organic sales growth in Europe was led by businesses in France, which was partially offset by a decline in organic sales throughout the remainder of Western Europe.
Organic sales in North America declined in the low-single digits for the three months ended April 30, 2021, compared to the same period in the prior year. Due to the increased digital marketing efforts around demand for personal protective
20

Table of Contents
equipment and other social distancing signage and floor markings resulting from the COVID-19 pandemic, the business realized increased sales of these products during the second half of fiscal 2020. Demand for these products declined and COVID-19 pandemic-related product sales did not replace the decline in demand for core safety and identification products in the three months ended April 30, 2021 compared to the same period in the prior year. Digital sales increased in the high-single digits and sales through the catalog channel decreased in the low-single digits in the three months ended April 30, 2021.
Organic sales in North America declined in the mid-single digits for the nine months ended April 30, 2021, compared to the same period in the prior year. The decline was driven by one of our businesses in the United States that sells primarily to small companies, which resulted in a significant decline in sales at the beginning of the COVID-19 pandemic and has only recently annualized the significant sales declines realized in the prior year. Digital sales increased in the mid-single digits and sales through the catalog channel decreased in the high-single digits in the nine months ended April 30, 2021.
Organic sales in Australia declined in the high-teens for the three months ended April 30, 2021, compared to the same period in the prior year. The WPS Australia business refined its digital marketing efforts to focus on the increase in demand for personal protective equipment and other social distancing signage and floor markings resulting from the COVID-19 pandemic. These actions resulted in significant organic sales growth in Australia in the second half of fiscal 2020 and the first half of fiscal 2021. The business continues to sell COVID-19 pandemic-related products including personal protective equipment, social distancing signage and floor markings, but demand has decreased significantly compared to the organic sales growth of nearly 30% that the business generated in the three months ended April 30, 2020.
Organic sales in Australia declined in the mid-single digits for the nine months ended April 30, 2021, compared to the same period in the prior year. Organic sales growth from COVID-19 pandemic-related products began to slow during the second quarter of fiscal 2021, while demand for core safety and identification products did not replace the decrease in sales of COVID-19 pandemic-related products. Organic sales increased in the high-single digits in the nine months ended April 30, 2020.
Segment profit increased 29.2% to $5.7 million from $4.4 million and as a percentage of net sales, segment profit increased to 7.3% from 6.0% for the three months ended April 30, 2021, compared to the same period in the prior year. Segment profit increased 14.1% to $17.1 million from $15.0 million and as a percentage of net sales, segment profit increased to 7.5% from 6.9% for the nine months ended April 30, 2021, compared to the same period in the prior year. The increase in segment profit in both the three and nine-month periods was primarily due to increased sales in the current year and the additional costs incurred in the prior year to address our cost structure.
Liquidity and Capital Resources
The Company's cash balances are generated and held in numerous locations throughout the world. At April 30, 2021, approximately 70% of the Company's cash and cash equivalents were held outside the United States. The Company's growth has historically been funded by a combination of cash provided by operating activities and debt financing. The Company believes that its cash flow from operating activities and its borrowing capacity are sufficient to fund its anticipated requirements for working capital, capital expenditures, research and development, common stock repurchases, and dividend payments for the next 12 months. Although the Company believes these sources of cash are currently sufficient to fund domestic operations, annual cash needs could require repatriation of cash to the U.S. from foreign jurisdictions, which may result in additional tax payments.
Cash Flows
Cash and cash equivalents were $321.8 million at April 30, 2021, an increase of $104.2 million from July 31, 2020. The significant changes were as follows:

| Nine months ended April 30,
(Dollars in thousands) | 2021 |  | 2020
Net cash flow provided by (used in): |  |  |
Operating activities | $ | 154,908 |  |  | $ | 95,913 |
Investing activities | (18,844) |  |  | (26,035) |
Financing activities | (39,274) |  |  | (101,047) |
Effect of exchange rate changes on cash | 7,368 |  |  | (9,023) |
Net increase (decrease) in cash and cash equivalents | $ | 104,158 |  |  | $ | (40,192) |

Net cash provided by operating activities was $154.9 million for the nine months ended April 30, 2021, compared to $95.9 million in the same period of the prior year. The increase was primarily due to an increase in net income and an increase in cash
21

Table of Contents
provided by working capital. Inventory levels were reduced which resulted in an increase in cash provided by operating activities, which was due to a planned reduction in inventory following a period of increased inventory levels to reduce the risk of supply chain disruption resulting from the COVID-19 pandemic. In addition, annual incentive compensation payments were lower in the current nine-month period compared to the same period in the prior year. This was partially offset by a decrease in cash provided by accounts receivable due to increased sequential sales during the nine months ended April 30, 2021.
Net cash used in investing activities was $18.8 million for the nine months ended April 30, 2021, compared to $26.0 million in the same period of the prior year. The decrease in net cash used in investing activities relates was primarily due to the proceeds received from the sale of a facility during the nine months ended April 30, 2021.
Net cash used in financing activities was $39.3 million during the nine months ended April 30, 2021, compared to $101.0 million in the same period of the prior year. The decrease in cash used in financing activities was due to a decrease in cash used for share repurchases from $64.1 million in the nine months ended April 30, 2020 to $3.6 million in the nine months ended April 30, 2021.
Credit Facilities
On August 1, 2019, the Company and certain of its subsidiaries entered into an unsecured $200 million multi-currency revolving loan agreement with a group of five banks that replaced and terminated the Company’s previous loan agreement that had been entered into on September 25, 2015. Under the new revolving loan agreement, the Company has the option to select either a Eurocurrency rate loan that bears interest at the LIBOR rate plus a margin based on the Company's consolidated net leverage ratio or a base interest rate (based upon the higher of the federal funds rate plus 0.5%, the prime rate of the Bank of Montreal plus a margin based on the Company’s consolidated net leverage ratio, or the Eurocurrency base rate at the LIBOR rate plus a margin based on the Company’s consolidated net leverage ratio plus 1%). At the Company's option, and subject to certain conditions, the available amount under the revolving loan agreement may be increased from $200 million to $400 million. The maximum amount outstanding on the Company's revolving loan agreement during the nine months ended April 30, 2021 was $10.6 million. As of April 30, 2021, there were no borrowings outstanding on the credit facility. The Company had letters of credit outstanding under the loan agreement of $3.6 million as of April 30, 2021 and there was $196.4 million available for future borrowing, which can be increased to $396.4 million at the Company's option, subject to certain conditions. The revolving loan agreement has a final maturity date of August 1, 2024, as such, any borrowing would be classified as long-term on the condensed consolidated balance sheets.
Covenant Compliance
The Company’s revolving loan agreement requires it to maintain certain financial covenants, including a ratio of debt to the trailing twelve months EBITDA, as defined in the debt agreements, of not more than a 3.5 to 1.0 ratio (leverage ratio) and the trailing twelve months EBITDA to interest expense of not less than a 3.0 to 1.0 ratio (interest expense coverage ratio). As of April 30, 2021, the Company was in compliance with these financial covenants.
Off-Balance Sheet Arrangements
The Company does not have material off-balance sheet arrangements. The Company is not aware of factors that are reasonably likely to adversely affect liquidity trends, other than the risk factors described in this Quarterly Report and its other filings with the Securities and Exchange Commission. However, the following additional information is provided to assist those reviewing the Company’s financial statements.
Purchase Commitments - The Company has purchase commitments for materials, supplies, services, and property, plant and equipment as part of the ordinary conduct of its business. In the aggregate, such commitments are not in excess of current market prices and are not material to the financial position of the Company. Due to the proprietary nature of many of the Company’s materials and processes, certain supply contracts contain penalty provisions for early termination. The Company does not believe a material amount of penalties will be incurred under these contracts based upon historical experience and current expectations.
Other Contractual Obligations - The Company does not have material financial guarantees or other contractual commitments that are reasonably likely to adversely affect liquidity.
Forward-Looking Statements
In this quarterly report on Form 10-Q, statements that are not reported financial results or other historic information are “forward-looking statements.” These forward-looking statements relate to, among other things, the Company's future financial
22

Table of Contents
position, business strategy, targets, projected sales, costs, income, capital expenditures, debt levels and cash flows, and plans and objectives of management for future operations.
The use of words such as “may,” “will,” “expect,” “intend,” “estimate,” “anticipate,” “believe,” “should,” “project” or “plan” or similar terminology are generally intended to identify forward-looking statements. These forward-looking statements by their nature address matters that are, to different degrees, uncertain and are subject to risks, assumptions, and other factors, some of which are beyond Brady's control, that could cause actual results to differ materially from those expressed or implied by such forward-looking statements. For Brady, uncertainties arise from:
•Adverse impacts of the novel coronavirus ("COVID-19") pandemic or other pandemics
•Decreased demand for the Company's products
•Ability to compete effectively or to successfully execute its strategy
•Ability to develop technologically advanced products that meet customer demands
•Raw material and other cost increases
•Difficulties in protecting websites, networks, and systems against security breaches
•Extensive regulations by U.S. and non-U.S. governmental and self-regulatory entities
•Risks associated with the loss of key employees
•Divestitures, contingent liabilities from divestitures and the failure to identify, integrate, and grow acquired companies
•Litigation, including product liability claims
•Foreign currency fluctuations
•Potential write-offs of goodwill and other intangible assets
•Changes in tax legislation and tax rates
•Differing interests of voting and non-voting shareholders
•Numerous other matters of national, regional and global scale, including major public health crises and government responses thereto and those of a political, economic, business, competitive, and regulatory nature contained from time to time in Brady's U.S. Securities and Exchange Commission filings, including, but not limited to, those factors listed in the “Risk Factors” section set forth in this report and within Item 1A of Part I of Brady's Form 10-K for the year ended July 31, 2020.
These uncertainties may cause Brady's actual future results to be materially different than those expressed in its forward-looking statements. Brady does not undertake to update its forward-looking statements except as required by law.
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
Refer to the Company’s Annual Report on Form 10-K for the year ended July 31, 2020. There has been no material change in this information since July 31, 2020.
ITEM 4. CONTROLS AND PROCEDURES
Brady Corporation maintains a set of disclosure controls and procedures that are designed to ensure that information required to be disclosed by the Company in the reports filed by the Company under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by the Company in the reports the Company files under the Exchange Act is accumulated and communicated to the Company’s management, including the Company’s principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. The Company carried out an evaluation, under the supervision and with the participation of its management, including its President and Chief Executive Officer and its Chief Financial Officer and Treasurer, of the effectiveness of the design and operation of the Company’s disclosure controls and procedures pursuant to Rule 13a-15 of the Exchange Act. Based on that evaluation, the Company’s President & Chief Executive Officer and Chief Financial Officer and Treasurer concluded that the Company’s disclosure controls and procedures are effective as of the end of the period covered by this report.
There were no changes in the Company's internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) that occurred during the Company's most recently completed fiscal quarter that have materially affected, or are reasonably likely to materially affect, the Company's internal control over financial reporting.
23

Table of Contents
PART II. OTHER INFORMATION
ITEM 1A. RISK FACTORS
The Company’s business, results of operations, financial condition, and cash flows are subject to various risks and uncertainties, including those described in Part I, Item 1A, “Risk Factors” of Brady's Annual Report on Form 10-K for the year ended July 31, 2020. Other than as set forth below, there have been no material changes from the risk factors set forth in the 2020 Form 10-K.
The COVID-19 pandemic has significantly impacted worldwide economic conditions and could continue to have a material adverse effect on our operations and business.
The ongoing COVID-19 pandemic initially impacted our operations in the third quarter of fiscal 2020, and may continue to affect our business, particularly if conditions worsen and government authorities impose new or expanded mandatory closures, work-from-home orders or social distancing protocols, seek voluntary facility closures or impose other restrictions. Such actions could adversely affect our ability to adequately staff and maintain our operations and negatively impact our financial results. The effects of the COVID-19 pandemic also may include restrictions on our employees’ ability to visit customers as well as disruptions or temporary closures of our facilities.
In response to the COVID-19 pandemic, we have enabled remote working arrangements, which may create increased vulnerability to cybersecurity incidents, including breaches of information systems security. Such incidents could damage our reputation and commercial relationships, disrupt operations, increase costs or decrease revenues, and expose us to claims from customers, suppliers, financial institutions, regulators, payment card associations, employees and others.
While we attempt to maintain sufficient inventory levels in order to meet rapidly shifting customer demand patterns and supplier lead time requirements, we cannot be certain we will be able to accurately predict demand or lead times, which may cause us to be unable to service customer demand or expose us to risks of product shortages, or result in excess inventory, which could lead to additional inventory carrying costs and inventory obsolescence.
The duration and ultimate impact of the COVID-19 pandemic on our business, results of operations and financial condition, including liquidity, capital and financing resources, will depend on numerous evolving factors and future developments. Such factors and developments may include the geographic spread, severity and duration of the COVID-19 pandemic, including whether there are periods of increased COVID-19 cases or other variants, disruption to our operations resulting from employee illnesses, the availability and administration of effective treatment or vaccines, as well as vaccination rates, the extent and duration of the impact on the U.S. and global economy, including the pace and extent of recovery as the pandemic subsides, and the actions that have been or may be taken by various governmental authorities in response to the outbreak, including current and future health and safety measures, such as mandatory facility closures of non-essential businesses, stay-at-home orders or similar restrictions, social distancing mandates and travel bans, and import and export restrictions, which could disrupt our relationship with customers. If we are unable to respond to and manage the impact of these events, our business and results of operations may be adversely affected.
Although our accounting estimates contemplate current and expected future conditions, as applicable, it is reasonably possible that actual conditions could differ from our expectations, which could materially affect our results of operations and financial position. As a result, our accounting estimates and assumptions may change over time in response to COVID-19. Such changes could result in future impairments of goodwill, intangible assets, long-lived assets, incremental credit losses on accounts receivable, excess and obsolete inventory, or a decrease in the carrying amount of our deferred tax assets. Any of these events could amplify the other risks and uncertainties described in our Annual Report on Form 10-K for the fiscal year ended July 31, 2020 and could have an adverse effect on our business and financial results.
24

Table of Contents
ITEM 6. EXHIBITS

Exhibit No. |  | Exhibit Description
2.1 |  | Combination Agreement, dated as of April 15, 2021, by and among Brady Corporation and Nordic ID Ovi (incorporated by reference to Exhibit 2.1 to the Company's Current Report on Form 8-K, dated April 15, 2021)
31.1 |  | Rule 13a-14(a)/15d-14(a) Certification of J. Michael Nauman
31.2 |  | Rule 13a-14(a)/15d-14(a) Certification of Aaron J. Pearce
32.1 |  | Section 1350 Certification of J. Michael Nauman
32.2 |  | Section 1350 Certification of Aaron J. Pearce
101.INS |  | XBRL Instance Document (The instance document does not appear in the interactive data file because its XBRL tags are embedded within the inline XBRL document.)
101.SCH |  | XBRL Taxonomy Schema Document
101.CAL |  | XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF |  | XBRL Taxonomy Extension Definition Linkbase Document
101.LAB |  | XBRL Taxonomy Extension Label Linkbase Document
101.PRE |  | XBRL Taxonomy Presentation Label Linkbase Document
104 |  | Cover Page Inline XBRL data (contained in Exhibit 101)

25

Table of Contents
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
SIGNATURES

|  |  |  |  |  | BRADY CORPORATION
Date: May 20, 2021 |  |  |  |  |  | /s/ J. MICHAEL NAUMAN
|  |  |  |  |  | J. Michael Nauman
|  |  |  |  |  | President and Chief Executive Officer
|  |  |  |  |  | (Principal Executive Officer)
Date: May 20, 2021 |  |  |  |  |  | /s/ AARON J. PEARCE
|  |  |  |  |  | Aaron J. Pearce
|  |  |  |  |  | Chief Financial Officer and Treasurer
|  |  |  |  |  | (Principal Financial Officer)

26